{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:49:01Z","timestamp":1752551341904,"version":"3.32.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1994,7]]},"DOI":"10.1007\/bf02088051","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T08:36:48Z","timestamp":1124008608000},"page":"1473-1482","source":"Crossref","is-referenced-by-count":3,"title":["Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer"],"prefix":"10.1007","volume":"39","author":[{"given":"Vincenzo","family":"Savarino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Sandro","family":"Mela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Zentilin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Cutela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Raffaella","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Perilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrogio","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Zambotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Celle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02088051_CR1","first-page":"607","volume":"83","author":"SJ Sontag","year":"1988","unstructured":"Sontag SJ: Current status of maintenance therapy in peptic ulcer disease. Am J Gastroenterol 83:607\u2013617, 1988","journal-title":"Am J Gastroenterol"},{"key":"BF02088051_CR2","first-page":"482","volume":"7","author":"G Bianchi Porro","year":"1991","unstructured":"Bianchi Porro G, Parente F: Long term treatment of duodenal ulcer. A review of management options. Drugs 7:482\u2013487, 1991","journal-title":"Drugs"},{"issue":"suppl 4B","key":"BF02088051_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-9343(86)90599-1","volume":"81","author":"DM Jensen","year":"1986","unstructured":"Jensen DM: Economic and health aspects of peptic ulcer disease and H2-receptor antagonists. Am J Med 81(suppl 4B):42\u201348, 1986","journal-title":"Am J Med"},{"key":"BF02088051_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2036.1987.tb00623.x","volume":"1","author":"S Lanzon Miller","year":"1987","unstructured":"Lanzon Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NAF, Raymond F, Olausson M, Cederberg C: Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine and omeprazole. Aliment Pharmacol Ther 1:239\u2013251, 1987","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02088051_CR5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM199104043241406","volume":"324","author":"PN Maton","year":"1991","unstructured":"Maton PN: Omeprazole. N Engl J Med 324:965\u2013975, 1991","journal-title":"N Engl J Med"},{"key":"BF02088051_CR6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1136\/gut.29.12.1715","volume":"29","author":"EG Hewson","year":"1988","unstructured":"Hewson EG, Yeomans ND, Angus PW, Shulkes A, Brook CW, Sewell RB, Smallwood RA: Effect of \u201cweekend therapy\u201d with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients. Gut 29:1715\u20131720, 1988","journal-title":"Gut"},{"key":"BF02088051_CR7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gut.32.9.977","volume":"32","author":"LC Baak","year":"1991","unstructured":"Baak LC, Jansen JBMJ, Biemond I, Lamers CBHW: Weekend treatment with 20 and 40 mg omeprazole: Effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens. Gut 32:977\u2013982, 1991","journal-title":"Gut"},{"key":"BF02088051_CR8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000199615","volume":"38","author":"R Lamberts","year":"1988","unstructured":"Lamberts R, Creutzfeldt Stockmann F, Jacubaschke U, Maas S, Brunner G: Long-term omeprazole treatment in man: Effects on gastric endocrine cell populations. Digestion 38:126\u2013135, 1988","journal-title":"Digestion"},{"issue":"suppl 166","key":"BF02088051_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00365528909091260","volume":"24","author":"E Solcia","year":"1989","unstructured":"Solcia E, Rindi G, Havu N, Elm G: Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol 24(suppl 166):129\u2013137, 1989","journal-title":"Scand J Gastroenterol"},{"key":"BF02088051_CR10","unstructured":"Dayal Y, Berlin R, Collen M, Bhatnager R: Does prolonged omeprazole administration affect enterochromaffin-like cell populations in hypersecretors? Gastroenterology 96:A113, 1989"},{"key":"BF02088051_CR11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/00365529109025038","volume":"26","author":"L Lundell","year":"1991","unstructured":"Lundell L, Backman L, Ekstrom P, Enander L-K, Falkner S, Fausa O, Grimelius L, Havu N, Lind T, Lonroth H, Sandmark S, Sandzen B, Unge P, Westin IH: Prevention of relapse of reflux oesophagitis after endoscopic healing: The efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 26:248\u2013256, 1991","journal-title":"Scand J Gastroenterol"},{"key":"BF02088051_CR12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.24.4.270","volume":"24","author":"T Lind","year":"1983","unstructured":"Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: Effect of omeprazole\u2014a gastric proton pump inhibitor\u2014on pentagastrin stimulated acid secretion in man. Gut 24:270\u2013276, 1983","journal-title":"Gut"},{"key":"BF02088051_CR13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.25.9.957","volume":"25","author":"BK Sharma","year":"1984","unstructured":"Sharma BK, Walt RP, Pounder RE, Gomes MD, Wood EC, Logan RH: Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 25:957\u2013964, 1984","journal-title":"Gut"},{"key":"BF02088051_CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(83)91596-9","volume":"1","author":"P M\u00fcller","year":"1983","unstructured":"M\u00fcller P, Dammann HG, Seitz H, Simon B: Effect of repeated, once daily, oral omeprazole on gastric secretion. Lancet 1:66, 1983","journal-title":"Lancet"},{"key":"BF02088051_CR15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00365528708991870","volume":"22","author":"V Savarino","year":"1987","unstructured":"Savarino V, Mela GS, Scalabrini P, Magnolia MR, Percario G, Di Timoteo E, Celle G: 24 hour comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. Scand J Gastroenterol 22:135\u2013140, 1987","journal-title":"Scand J Gastroenterol"},{"key":"BF02088051_CR16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/00365528909093071","volume":"24","author":"V Savarino","year":"1989","unstructured":"Savarino V, Mela GS, Zentilin P, Magnolia MR, Scalabrini P, Valle F, Moretti M, Bonifacino G, Celle G: Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparativein vivo study. Scand J Gastroenterol 24:434\u2013439, 1989","journal-title":"Scand J Gastroenterol"},{"key":"BF02088051_CR17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/BF01540564","volume":"36","author":"GS Mela","year":"1990","unstructured":"Mela GS, Savarino V, Moretti M, Sumberaz A, Bonifacino G, Zentilin P, Caputo E, Villa G, Celle G: Antimony and glass pH electrodes can be used interchangeability in 24-hour studies of gastric acidity. Dig Dis Sci 36:1473\u20131481, 1990","journal-title":"Dig Dis Sci"},{"key":"BF02088051_CR18","first-page":"826","volume":"10","author":"V Savarino","year":"1986","unstructured":"Savarino V, Mela GS, Scalabrini P, Magnolia MR, Di Timoteo E, Percario G, Celle G: Continuous intragastric pH monitoring: Focus on its reproducibility in duodenal ulcer patients. A preliminary report. Gastroenterol Clin Biol 10:826\u2013830, 1986","journal-title":"Gastroenterol Clin Biol"},{"key":"BF02088051_CR19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/00365528909093109","volume":"24","author":"GS Mela","year":"1989","unstructured":"Mela GS, Savarino V, Moretti M, Bonifacino G, Sumberaz A, Zentilin P: Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. Scand J Gastroenterol 24:683\u2013687, 1989","journal-title":"Scand J Gastroenterol"},{"key":"BF02088051_CR20","first-page":"1105","volume":"85","author":"GS Mela","year":"1990","unstructured":"Mela GS, Savarino V, Sumberaz A, Bonifacino G, Zentilin P, Villa G, Caputo E: Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median? Am J Gastroenterol 85:1105\u20131108, 1990","journal-title":"Am J Gastroenterol"},{"key":"BF02088051_CR21","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0016-5085(16)34602-9","volume":"100","author":"GS Mela","year":"1991","unstructured":"Mela GS, Savarino V: Relationship between ulcer healing and acid suppression. Gastroenterology 100:1482\u20131483, 1991","journal-title":"Gastroenterology"},{"key":"BF02088051_CR22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/BF01536371","volume":"34","author":"V Savarino","year":"1989","unstructured":"Savarino V, Mela GS, Zentilin P, Bonifacino G, Moretti M, Valle F, Celle G: Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. Dig Dis Sci 34:1043\u20131046, 1989","journal-title":"Dig Dis Sci"},{"key":"BF02088051_CR23","first-page":"267","volume":"33","author":"CW Howden","year":"1986","unstructured":"Howden CW, Derodra JK, Burget DW, Hunt RH: Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer. Hepato-Gastroenterol 33:267\u2013270, 1986","journal-title":"Hepato-Gastroenterol"},{"key":"BF02088051_CR24","first-page":"148","volume":"11","author":"P Hemery","year":"1987","unstructured":"Hemery P, Galmiche JP, Roze C, Isal J-P, Bruley des Varennes S, Lavignolle A, Le Bodic L: Low dose omeprazole effects on gastric acid secretion in normal man. Gastroenterol Clin Biol 11:148\u2013153, 1987","journal-title":"Gastroenterol Clin Biol"},{"key":"BF02088051_CR25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0016-5085(91)80009-X","volume":"100","author":"K Lauritsen","year":"1991","unstructured":"Lauritsen K, Andersen BN, Laursen LS, Hansen J, Havelund T, Eriksen J, Rehfeld JF, Kjaergaard J, Rask-Madsen J: Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial. Gastroenterology 100:663\u2013669, 1991","journal-title":"Gastroenterology"},{"key":"BF02088051_CR26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2165\/00003495-199142010-00008","volume":"42","author":"D McTavish","year":"1991","unstructured":"McTavish D, Buckley MM-T, Heel RC: Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 42:138\u2013170, 1991","journal-title":"Drugs"},{"key":"BF02088051_CR27","doi-asserted-by":"crossref","unstructured":"Savarino V, Mela GS, Zentilin P, Cutela P, Mele MR, Vigneri S, Celle G: Variability in individual response to various doses of omeprazole: Implications for antiulcer therapy. Dig Dis Sci (in press)","DOI":"10.1007\/BF02090077"},{"key":"BF02088051_CR28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3109\/00365528809090202","volume":"23","author":"T Lind","year":"1988","unstructured":"Lind T, Cederberg C, Forssell H, Olausson M, Olbe L: Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol 23:1259\u20131266, 1988","journal-title":"Scand J Gastroenterol"},{"key":"BF02088051_CR29","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/0016-5085(90)91000-V","volume":"99","author":"V Savarino","year":"1990","unstructured":"Savarino V, Mela GS, Zentilin P, Celle G: Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? Gastroenterology 99:1858\u20131860, 1990","journal-title":"Gastroenterology"},{"issue":"suppl 146","key":"BF02088051_CR30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/00365528809099128","volume":"23","author":"RH Hunt","year":"1988","unstructured":"Hunt RH: The protective role of gastric acid. Scand J Gastroenterol 23(suppl 146):34\u201339, 1988","journal-title":"Scand J Gastroenterol"},{"issue":"suppl 1","key":"BF02088051_CR31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000200923","volume":"51","author":"JW Freston","year":"1992","unstructured":"Freston JW: Clinical significance of hypergastrinemia: Relevance to gastrin monitoring during omeprazole therapy. Digestion 51(suppl 1):102\u2013114, 1992","journal-title":"Digestion"},{"key":"BF02088051_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.1992.tb00541.x","volume":"6","author":"JG Penston","year":"1992","unstructured":"Penston JG, Wormsley KG: Review article: Maintenance treatment with H2-receptor antagonists for peptic ulcer disease. Aliment Pharmacol Ther 6:3\u201329, 1992","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02088051_CR33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2036.1992.tb00577.x","volume":"6","author":"JG Penston","year":"1992","unstructured":"Penston JG, Wormsley KG: Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Aliment Pharmacol Ther 6:629\u2013645, 1992","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02088051_CR34","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bmj.297.6660.1393","volume":"297","author":"CW Howden","year":"1988","unstructured":"Howden CW: Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: Rarely justified in terms of cost or patient benefit. Br Med J 297:1393\u20131394, 1988","journal-title":"Br Med J"},{"key":"BF02088051_CR35","first-page":"3","volume":"3","author":"KD Bardhan","year":"1990","unstructured":"Bardhan KD, Hollander D, Festen HPM, Bianchi Porro G: Changing strategies for peptic ulcer disease. Gastroenterol Int 3:3\u201321, 1990","journal-title":"Gastroenterol Int"},{"key":"BF02088051_CR36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2036.1990.tb00011.x","volume":"4S","author":"JTL Smith","year":"1990","unstructured":"Smith JTL, Gavey C, Nwokolo CU, Pounder RE: Tolerance during 8 days of high-dose H2-blockade: Placebo-controlled studies of 24-h acidity and gastrin. Aliment Pharmacol Ther 4S:47\u201364, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02088051_CR37","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/BF01537246","volume":"35","author":"CH Wilder-Smith","year":"1990","unstructured":"Wilder-Smith CH, Ernst T, Gennoni M, Zeyen B, Halter F, Merki HS: Tolerance to oral H2-receptor antagonists. Dig Dis Sci 35:976\u2013983, 1990","journal-title":"Dig Dis Sci"},{"key":"BF02088051_CR38","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(90)91301-P","volume":"2","author":"EAJ Rauws","year":"1990","unstructured":"Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 2:1233\u20131235, 1990","journal-title":"Lancet"},{"key":"BF02088051_CR39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199106273242623","volume":"324","author":"WL Peterson","year":"1991","unstructured":"Peterson WL:Helicobacter pylori and peptic ulcer disease. N Engl J Med 324:1043\u20131048, 1991","journal-title":"N Engl J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02088051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02088051\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02088051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T14:36:35Z","timestamp":1735914995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02088051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["BF02088051"],"URL":"https:\/\/doi.org\/10.1007\/bf02088051","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}